These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37839510)

  • 1. Proteomics-Based Mapping of Bronchopulmonary Dysplasia-Associated Changes in Noninvasively Accessible Oral Secretions.
    Ahmed S; Odumade OA; van Zalm P; Fatou B; Hansen R; Martin CR; Angelidou A; Steen H
    J Pediatr; 2024 Jul; 270():113774. PubMed ID: 37839510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlates of Elevated Interleukin-6 and 8-Hydroxy-2'-Deoxyguanosine Levels in Tracheal Aspirates from Very Low Birth Weight Infants Who Develop Bronchopulmonary Dysplasia.
    Hsiao CC; Chang JC; Tsao LY; Yang RC; Chen HN; Lee CH; Lin CY; Tsai YG
    Pediatr Neonatol; 2017 Feb; 58(1):63-69. PubMed ID: 27321203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevation of interleukin-8 and interleukin-6 precedes the influx of neutrophils in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia.
    Munshi UK; Niu JO; Siddiq MM; Parton LA
    Pediatr Pulmonol; 1997 Nov; 24(5):331-6. PubMed ID: 9407566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urine Proteomics for Noninvasive Monitoring of Biomarkers in Bronchopulmonary Dysplasia.
    Ahmed S; Odumade OA; van Zalm P; Smolen KK; Fujimura K; Muntel J; Rotunno MS; Winston AB; Steen JA; Parad RB; Van Marter LJ; Kourembanas S; Steen H
    Neonatology; 2022; 119(2):193-203. PubMed ID: 35073553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exhaled breath condensate nitrite in premature infants with bronchopulmonary dysplasia.
    Yen E; Weinberger BI; Laumbach RJ; Ohman-Strickland PA; Vetrano AM; Gow AM; Ramagopal M
    J Neonatal Perinatal Med; 2018; 11(4):399-407. PubMed ID: 30040745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceramides in tracheal aspirates of preterm infants: Marker for bronchopulmonary dysplasia.
    van Mastrigt E; Zweekhorst S; Bol B; Tibboel J; van Rosmalen J; Samsom JN; Kroon AA; de Jongste JC; Reiss IKM; Post M; Pijnenburg MW
    PLoS One; 2018; 13(1):e0185969. PubMed ID: 29346372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of new biomarkers of bronchopulmonary dysplasia using metabolomics.
    Piersigilli F; Lam TT; Vernocchi P; Quagliariello A; Putignani L; Aghai ZH; Bhandari V
    Metabolomics; 2019 Feb; 15(2):20. PubMed ID: 30830433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low serum IGF-1 and increased cytokine levels in tracheal aspirate samples are associated with bronchopulmonary dysplasia.
    Yılmaz C; Köksal N; Özkan H; Dorum BA; Bağcı O
    Turk J Pediatr; 2017; 59(2):122-129. PubMed ID: 29276864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phthalate exposure in the neonatal intensive care unit is associated with development of bronchopulmonary dysplasia.
    Stroustrup A; Zhang X; Spear E; Bandyopadhyay S; Narasimhan S; Meher AK; Choi J; Qi G; Poindexter BB; Teitelbaum SL; Andra SS; Gennings C; Aschner JL
    Environ Int; 2023 Aug; 178():108117. PubMed ID: 37517179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Airway nitrite is increased in extremely preterm infants with bronchopulmonary dysplasia.
    Gentle SJ; Freeman A; Patel RP; Ambalavanan N; Lal CV
    Respir Res; 2020 Sep; 21(1):244. PubMed ID: 32957939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early increase in endothelin-1 in tracheal aspirates of preterm infants: correlation with bronchopulmonary dysplasia.
    Niu JO; Munshi UK; Siddiq MM; Parton LA
    J Pediatr; 1998 Jun; 132(6):965-70. PubMed ID: 9627587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early airway microbial metagenomic and metabolomic signatures are associated with development of severe bronchopulmonary dysplasia.
    Lal CV; Kandasamy J; Dolma K; Ramani M; Kumar R; Wilson L; Aghai Z; Barnes S; Blalock JE; Gaggar A; Bhandari V; Ambalavanan N
    Am J Physiol Lung Cell Mol Physiol; 2018 Nov; 315(5):L810-L815. PubMed ID: 30113227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tracheal aspirate VEGF and sphingolipid metabolites in the preterm infant with later development of bronchopulmonary dysplasia.
    Hendricks-Muñoz KD; Xu J; Voynow JA
    Pediatr Pulmonol; 2018 Aug; 53(8):1046-1052. PubMed ID: 29687638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchopulmonary dysplasia in very preterm infants: Outcome up to preschool age, in a single center of Austria.
    Reiterer F; Scheuchenegger A; Resch B; Maurer-Fellbaum U; Avian A; Urlesberger B
    Pediatr Int; 2019 Apr; 61(4):381-387. PubMed ID: 30793436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early angiogenic proteins associated with high risk for bronchopulmonary dysplasia and pulmonary hypertension in preterm infants.
    Arjaans S; Wagner BD; Mourani PM; Mandell EW; Poindexter BB; Berger RMF; Abman SH
    Am J Physiol Lung Cell Mol Physiol; 2020 Apr; 318(4):L644-L654. PubMed ID: 31967847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum neurotrophins at birth correlate with respiratory and neurodevelopmental outcomes of premature infants.
    Simpson SL; Grayson S; Peterson JH; Moore JJ; Mhanna MJ; Perez MK; Rezaee F; Piedimonte G
    Pediatr Pulmonol; 2019 Mar; 54(3):303-312. PubMed ID: 30575339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preterm infants with high polyunsaturated fatty acid and plasmalogen content in tracheal aspirates develop bronchopulmonary dysplasia less often.
    Rüdiger M; von Baehr A; Haupt R; Wauer RR; Rüstow B
    Crit Care Med; 2000 May; 28(5):1572-7. PubMed ID: 10834714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative two time-point proteome analysis of the plasma from preterm infants with and without bronchopulmonary dysplasia.
    Zasada M; Suski M; Bokiniec R; Szwarc-Duma M; Borszewska-Kornacka MK; Madej J; Bujak-Giżycka B; Madetko-Talowska A; Revhaug C; Baumbusch LO; Saugstad OD; Pietrzyk JJ; Kwinta P
    Ital J Pediatr; 2019 Aug; 45(1):112. PubMed ID: 31445514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospital variation and risk factors for bronchopulmonary dysplasia in a population-based cohort.
    Lapcharoensap W; Gage SC; Kan P; Profit J; Shaw GM; Gould JB; Stevenson DK; O'Brodovich H; Lee HC
    JAMA Pediatr; 2015 Feb; 169(2):e143676. PubMed ID: 25642906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary metabolomics of bronchopulmonary dysplasia (BPD): preliminary data at birth suggest it is a congenital disease.
    Fanos V; Pintus MC; Lussu M; Atzori L; Noto A; Stronati M; Guimaraes H; Marcialis MA; Rocha G; Moretti C; Papoff P; Lacerenza S; Puddu S; Giuffrè M; Serraino F; Mussap M; Corsello G
    J Matern Fetal Neonatal Med; 2014 Oct; 27 Suppl 2():39-45. PubMed ID: 25284176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.